JenaValve Technology Inc. is engaged in design, development, manufacturing and marketing of transcatheter aortic valve replacement systems (TAVI) to treat patients with severe aortic stenosis. JenaVal...
JenaValve Technology Inc. is engaged in design, development, manufacturing and marketing of transcatheter aortic valve replacement systems (TAVI) to treat patients with severe aortic stenosis. JenaValve is a privately-held, venture capital backed U.S. corporation with operations in Munich, Germany. The Company's TAVI products are being sold primarily in Europe. Please visit www.jenavalve.com for more information.